CIK 0001827090 · Large accelerated filer
Certara, Inc.
Sign in to watch- Ticker
- CERT
- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (415) 237-8272
- Business address
- 4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale 10b5-1 | −51,224 | $10.92 | $559K | 73,979 |
| 2024-10-07 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −5,409 | $11.03 | $60K | 50,091 |
| 2024-09-09 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale 10b5-1 | −51,224 | $11.29 | $578K | 99,704 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −5,264 | $16.76 | $88K | 59,254 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −649 | $17.72 | $12K | 58,605 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −3,024 | $16.75 | $51K | 55,581 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −328 | $17.67 | $6K | 55,253 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −4,740 | $16.77 | $79K | 50,513 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −422 | $17.77 | $7K | 50,091 |
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −3,000 | $18.00 | $54K | 173,524 |
| 2024-03-04 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −3,000 | $18.28 | $55K | 162,368 |
| 2024-02-20 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −5,000 | $18.00 | $90K | 54,975 |
| 2024-02-12 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −6,000 | $18.00 | $108K | 165,368 |
| 2023-12-26 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −6,000 | $18.00 | $108K | 171,368 |
| 2023-09-11 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale 10b5-1 | −51,224 | $14.60 | $748K | 128,883 |
| 2023-06-05 | SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV | Sale 10b5-1 | −19,104 | $21.55 | $412K | 59,975 |
| 2023-05-11 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −5,000 | $20.82 | $104K | 177,368 |
| 2023-04-14 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −5,000 | $23.66 | $118K | 182,368 |
| 2023-03-06 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | −10,000 | $21.45 | $215K | 184,564 |
| 2023-02-02 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | −15,000 | $20.00 | $300K | 194,564 |
Page 1 of 8 · 149 trades